- Investing Ideas
- Hong Kong Pharmaceuticals & Biotech Profitable Climbers
Hong Kong Pharmaceuticals & Biotech Profitable Climbers
Results
10
10 companies
WuXi XDC Cayman
Market Cap: HK$70.8b
An investment holding company, operates as a contract research, development, and manufacturing organization in China, North America, Europe, and internationally.
2268
HK$54.20
7D
-2.3%
1Y
18.1%
Biocytogen Pharmaceuticals (Beijing)
Market Cap: HK$37.9b
A biotechnology company, engages in the research and development of novel antibody-based drugs and pre-clinical research services in the People’s Republic of China, the United States, and internationally.
2315
HK$51.65
7D
-6.9%
1Y
205.6%
RemeGen
Market Cap: HK$69.7b
A biopharmaceutical company, discovers, develops, produces, and commercializes biological drugs for the treatment of autoimmune, oncology, and ophthalmic diseases in Mainland China and the United States.
9995
HK$95.30
7D
10.6%
1Y
342.2%
CanSino Biologics
Market Cap: HK$14.2b
Develops, manufactures, and commercializes vaccines in the People’s Republic of China.
6185
HK$34.14
7D
0.2%
1Y
-4.8%
Consun Pharmaceutical Group
Market Cap: HK$14.6b
Researches and develops, manufactures, and sells Chinese medicines and medical contrast medium products in the People’s Republic of China.
1681
HK$16.38
7D
-4.5%
1Y
82.2%
JBM (Healthcare)
Market Cap: HK$2.2b
An investment holding company, engages in the manufacture, marketing, distribution, and sale of branded healthcare and wellness products in Hong Kong, Macau, Mainland China, and internationally.
2161
HK$2.71
7D
-1.8%
1Y
50.6%
Innovent Biologics
Market Cap: HK$147.2b
A biopharmaceutical company, engages in the research and development of antibody and protein medicine products in the People’s Republic of China, the United States, and internationally.
1801
HK$81.85
7D
0.1%
1Y
89.5%
Luye Pharma Group
Market Cap: HK$10.1b
Develops, produces, markets, and sells pharmaceutical products in the People’s Republic of China, the United States, Europe, and internationally.
2186
HK$2.42
7D
-2.4%
1Y
0.4%
China Medical System Holdings
Market Cap: HK$33.2b
An investment holding company, manufactures, sells, markets, and promotes pharmaceutical products in the People’s Republic of China.
867
HK$13.59
7D
2.5%
1Y
75.6%
Simcere Pharmaceutical Group
Market Cap: HK$31.5b
An investment holding company, engages in the research, development, manufacture, and sale of pharmaceutical products to distributors, pharmacy chains, and other pharmaceutical manufacturers in China.
2096
HK$11.76
7D
0.8%
1Y
45.2%